Gene Editing Companies Hit Back At Paper That Criticized CRISPR
Jun 12, 2017, 09:58 AM
by
Michael Croft
MIT Technology Review | Report that suggested CRISPR is too dangerous to use as a drug was wrong, say biotech companies.
June 12, 2017 | Report that suggested CRISPR is too dangerous to use as a drug was wrong, say biotech companies. MIT Technology Review